Scott Fotheringham, PhD

Placeholder Person Graphic
Scott Fotheringham, PhD, is a freelance medical writer with interests that span fields as diverse as medical cannabis, pharmaceuticals, biotechnology, and molecular genetics. Most recently, he was Senior Medical Writer at Spectrum Therapeutics.

Related Articles

Emerging Leaders Cover
Features
Emerging Leaders: Nurturing Emerging Talent & the Workforce of the Future
Emerging Leaders has grown from an initiative for interactions among early-career professionals entering ISPE into much more: a training ground, a networking organization, and a new foundation for the future of ISPE and the industry. This article looks at the history of the group, its purpose,...
Women in Pharma®:Empowering Women as Industry Leaders
Features
Women in Pharma®: Empowering Women as Industry Leaders
Women in Pharma® is a place where women and men—especially those new to the industry—can access a network of mentors, role models, and educational resources to support their professional success. The widespread global interest and participation in this initiative and its events have shown that...
Technology Trends: The Transition to Digitalization
Features
Technology Trends: The Transition to Digitalization
In the pharmaceutical industry, digitalization involves developing and implementing digital technologies at all levels of pharmaceutical operations. The aim is to transform the industry by capturing, analyzing, and using vast amounts of data collected from a wide range of sources to support...
Article
Features
Biosimilars: Changing the Pharmaceutical Industry
Biologics are large-molecule drugs, derived from a biological source, that treat chronic diseases such as cancer and autoimmune disorders. While small-molecule compounds continue to account for the bulk of pharmaceutical profits, biologics’ presence is...
Italian Biopharma (Infographic)
Insights
Italian Biopharma
$38B of manufacturing value, 71% of which is exports 2nd in Europe for pharmaceutical production Italy exports 85% of the API it produces 42% of employees are women; 52% in R&D 40% of companies are Italian owned Exports have grown 52% since 2010,...